ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

$0.29
-0.01 (-3.29%)
As of Sep 29, 3:15 PM ET ·
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 9 60%
Hold 6 40%
Sell 0 0%
Price Target
Analyst Price Target +4,005.6% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $0.29
Current
$0.29
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
3,133.8%
Low target
Base Case
$11.82
+4,005.6%
Avg target
Bull Case
$19.97
+6,836.4%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$1.12
-74.3% from high
52-Week Low
$0.35
+-17.7% from low
Target vs 52W High
$11.82
+955.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%